Christopher Clinton Conway: My award-winning “CEO Perspective” blog!
Christopher Clinton Conway, CEO of the Dr. Susan Love Foundation for Breast Cancer Research, made the following post on LinkedIn:
“My award-winning “CEO Perspective” blog!
Zero Disease: The Case for Cause and Prevention
“One more breast cancer diagnosis is one too many. We must be the generation that ends it once and for all”. Dr. Susan Love
The idea of understanding the cause of the disease is necessary to prevent it. Russell Ackoff, the pioneering systems thinker and organization scholar, would agree with Dr. Love. He famously described the dangers of thinking in terms of curing a disease or solving a problem. Says Ackoff, “We walk into the future facing the past—we move away from, rather than toward, something. This often results in unforeseen consequences that are more distasteful than the deficiencies removed.”
The future of medicine is to prioritize keeping people healthy for longer periods. We are moving away from the tradition of “sick care” to genuine health care. This shift is a break from the now and then, when untold billions were spent on developing treatments for numerous health issues.
Medicine has been focused on the question: How do we develop better solutions for health problems in the form of advanced drugs or surgeries? Medicine should instead create and sustain health over curing disease. The goal is to promote lifelong preventive health practices to improve health span—the number of disease-free years in a person’s life. However, this approach is incompatible with the medical industry’s focus on extending lifespan—surviving the cycle of diseases and treatments. Medicine has been oriented towards the past: moving away from illness.
As Christian Seelos writes in this month’s Stanford Social Innovation Review, medicine needs to be oriented towards the future: building and maintaining health around a vision of ‘Zero Disease’.”
-
12:46 30/11/23 | BlogJohanna Joyce: the Flashlight method
-
12:31 30/11/23 | InsightJeff Ryckman: Omitting RT in bulky early-stage cHL
-
07:45 30/11/23 | BlogAaron Goodman: Hemoglobin Dissociation Curve! Good stuff
-
12:31 30/11Jeff Ryckman: Omitting RT in bulky early-stage cHL
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows